A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304

TerminatedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

September 30, 2016

Conditions
Adenovirus
Interventions
DRUG

Brincidofovir

Rates of adenovirus progression and mortality in subjects with adenovirus infection and/or disease. Sites participating in the CMX001-304 study will be asked to participate in the CMX001-305 study retrospective data collection study.

Trial Locations (22)

10021

Memorial Sloan Kettering, New York

10467

The Children's Hospital at Montefiore, The Bronx

15224

Children's Hospital of Pittsburgh, Pittsburgh

19104

The Children's Hospital of Philadelphia, Philadelphia

20010

Childrens National Health System, Washinton

27705

Duke University Medical Center, Durham

30322

Emory University, Atlanta

38105

St. Judes Children's Research Hospital, Memphis

45229

Cincinnati Children's Hosital, Cincinnati

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

60611

Lurie Children's Hospital of Chicago, Chicago

60637

University of Chicago, Chicago

63130

Washington University, St Louis

64108

Children's Mercy Hospital, Kansas City

68198

University of Nebraska, Omaha

70118

Children's Hospital New Orleans, New Orleans

84113

University of Utah, Salt Lake City

84143

Utah Cancer Specialist LDS Hospital, Salt Lake City

90027

Children's Hospital of Los Angeles, Los Angeles

98109

University of Washington_Fred Hutchinson Cancer Center, Seattle

02115

Brigham and Womens Hospital, Boston

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY